113075-66-4

Basic information

• Product Name: 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine
• Synonyms: 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine;1-(6-Bromo-3,4-dihydro-2-naphthalenyl)pyrrolidine;Pyrrolidine, 1-(6-bromo-3,4-dihydro-2-naphthalenyl)-
• CAS NO: 113075-66-4
• Molecular Formula: C₁₄H₁₆BrN
• Molecular Weight: 278.18754
• Mol File: 113075-66-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 370.7°C at 760 mmHg
• Flash Point: 178°C
• Appearance: /
• Density: 1.410
• Vapor Pressure: 1.09E-05mmHg at 25°C
• Refractive Index: 1.632
• CAS DataBase Reference: 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine(113075-66-4)
• EPA Substance Registry System: 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine(113075-66-4)

Safety Data

• Hazardous Substances Data: 113075-66-4(Hazardous Substances Data)

Usage

General Description

1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine is a chemical compound with the molecular formula C16H20BrN. It is a pyrrolidine derivative containing a bromine-substituted naphthalene ring. 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine is used in organic synthesis and pharmaceutical research as a building block for the preparation of various biologically active molecules. It may also have potential pharmacological or therapeutic applications, although further research is needed to fully understand its properties and potential uses. As a chemical, it should be handled and used with appropriate safety precautions in a controlled laboratory setting.

InChI:InChI=1/C14H16BrN/c15-13-5-3-12-10-14(6-4-11(12)9-13)16-7-1-2-8-16/h3,5,9-10H,1-2,4,6-8H2

Upstream product

• 123-75-1 pyrrolidine 
• 4133-35-1 6-bromo-2-tetralone 
• 66361-67-9 6-bromo-3,4-dihydro-2H-naphthalen-1-one 

Downstream Products

• 418772-22-2 1-(1-(RS)-benzyl-6-bromo-3,4-dihydro-1H-naphthalen-2-ylidene)-pyrrolidinium bromide 

Relevant articles and documents

PHENANTHRENONE COMPOUNDS, COMPOSITIONS AND METHODS

The present invention is directed to compounds of Formula (I) or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.

Hexahydrobenzo (f) quinolinones as 5-alpha-reductase inhibitors

The invention relates to 1,2,3,4,5,6-hexahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds, and their use as steroid 5α-reductase inhibitors.

Process for the preparation of benzo (F) quinolinones

This invention relates to a process for the preparation of hexa- and octahydrobenzo[f]quinolin-3-ones.